Physical Activity Breaks for Prediabetes
(BURST2D Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether breaking up long periods of sitting with short, frequent walking breaks (the BREAK intervention) can better control blood sugar levels compared to a single, longer walk each day. The focus is on individuals with prediabetes, where blood sugar levels are elevated but not yet high enough for a type 2 diabetes diagnosis. Participants will either take 5-minute walking breaks every hour or complete a single 45-minute walk daily, both for five days a week over three months. The study seeks individuals with prediabetes who sit for more than six hours a day and engage in less than 150 minutes of moderate exercise per week. As an Early Phase 1 trial, this research aims to understand how the BREAK intervention works in people, offering participants a chance to explore this innovative approach to managing prediabetes.
Will I have to stop taking my current medications?
You will need to stop taking any over-the-counter or prescribed medications (except oral contraceptives) for 3 days before certain study visits. The trial does not specify if you need to stop taking your medications for the entire study duration.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that taking short breaks for physical activity during long periods of sitting can help control blood sugar. Studies have found that frequent light activity breaks can significantly lower blood sugar and insulin levels. This suggests that taking these breaks may manage blood sugar more effectively than doing all exercise at once.
For the BREAK intervention, which involves taking 5-minute walks every hour, specific trial evidence on its safety is not yet available. However, as this is an early phase study, the main goal is to understand basic responses, including safety. Generally, light activities like walking are safe and pose a low risk of causing problems for most people.
Considering participation in a trial with this kind of activity is likely safe, but consulting a healthcare provider for personal advice is always recommended.12345Why are researchers excited about this trial?
Researchers are excited about the "Physical Activity Breaks for Prediabetes" trial because it explores a new way of managing prediabetes through structured activity. Unlike standard treatments like dietary changes and medication, this trial tests the impact of frequent, short bouts of brisk walking throughout the day. This method, involving 5-minute walks each hour, could offer a more sustainable and less daunting approach compared to longer, continuous exercise sessions. The trial aims to determine if these regular activity breaks can effectively regulate blood sugar levels, offering a potentially game-changing, non-pharmacological option for people with prediabetes.
What evidence suggests that this trial's treatments could be effective for prediabetes?
Research shows that taking short breaks from sitting to move around can help control blood sugar levels. Studies indicate that interrupting sitting time with light exercise reduces insulin resistance, a major factor in developing type 2 diabetes. One study found that doing a little physical activity every 30 minutes effectively lowers blood sugar. This method seems to work better than one longer exercise session each day. In this trial, participants in the BREAK intervention will perform 5-minute bouts of brisk walking hourly, while those in the ONE intervention will engage in a single 45-minute continuous bout of brisk walking. Regular exercise also helps muscles use insulin better, aiding in blood sugar control. These findings suggest that short, frequent activity breaks could be a promising way to help prevent type 2 diabetes in people with prediabetes.12346
Who Is on the Research Team?
Audrey Bergouignan, PhD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for sedentary adults aged 18-64 with prediabetes, defined by specific glucose levels. Participants should have a BMI of 18.5-40, be non-smokers, and not on medications that affect weight or metabolism. They must do less than 150 minutes of exercise weekly and sit for over 6 hours daily.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the BREAK or ONE intervention for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- BREAK
- ONE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor